Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2024-03-18 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official letter addressed to stock exchanges regarding the loss of share certificates and the issuance of duplicate certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the handling of lost or misplaced share certificates. The content is a formal notification about a specific administrative matter related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or any report publication. It is also not a regulatory filing in the sense of compliance or officer certification but a specific announcement related to share certificates. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-03-18 English
Please find enclosed the intimation letter dated March 18, 2024 received from our RTA, regarding loss of share certificates of the Company. The information is being submitted pursuant ....
Regulatory Filings Classification · 100% confidence The document is an official letter addressed to stock exchanges regarding the loss of share certificates and the issuance of duplicate certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the handling of lost or misplaced share certificates. The content is a notice to shareholders and the stock exchange about the lost certificates and the process for claims. There is no financial data, earnings information, management discussion, or report publication. The document is a regulatory announcement related to share certificate loss and does not fit into financial report categories like Annual Report, Earnings Release, or Interim Report. It is not a director dealing, capital change, or voting result announcement. The best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges and public about the upcoming investor meeting, explicitly stating that no unpublished price sensitive information will be shared. The document is short (1720 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement of a meeting schedule rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-03-11 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled analyst/institutional investor meeting. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The document explicitly states that no unpublished price sensitive information will be shared. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or detailed investor presentation. The document length is only 1720 characters, which is quite short and does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-03-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (1700 characters) addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, results, or detailed presentations. It explicitly states that no unpublished price sensitive information will be shared. This is an announcement about an upcoming investor meeting, not the meeting materials or transcript itself. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor engagement activities, but since it only announces the schedule and does not provide presentation content, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement without substantive financial or presentation content. Given the short length and nature of the document, Regulatory Filings (RNS) is the most accurate classification.
2024-03-11 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a short notice (1700 characters) addressed to stock exchanges about the schedule of meetings with analysts and institutional investors. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The document explicitly states it is an intimation of the schedule of meetings and does not contain any financial data or report content. It is not a financial report, earnings release, or presentation but an announcement of a meeting schedule. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2024-03-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.